Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCPA.L Regulatory News (SCPA)

  • There is currently no data for SCPA

Directorate Change

18 Apr 2016 07:00

RNS Number : 3904V
Scapa Group PLC
18 April 2016
 

18 April 2016

Scapa Group plc

('Scapa' or 'the Company')

 

Directorate Change

 

Scapa Group plc (AIM: SCPA), a global manufacturer of bonding materials and solutions for the Healthcare and Industrial markets, announces the following directorate changes.

Non-Executive Directors

David Blackwood has been appointed to the Board as an independent Non-Executive Director. He will join the Board on 1 May 2016 and chair the Audit and Risk Committee from 1 June 2016. Mr Blackwood is a Non-Executive Director of Dignity Plc and was previously Group Finance Director of Synthomer plc, a position from which he retired in May 2015. Prior to that, he was Group Treasurer at Imperial Chemical Industries plc ("ICI") and held a number of senior positions with ICI over a period of 22 years. He is a Chartered Accountant and a Fellow of the Association of Corporate Treasurers.

As a Non-Executive Director of Scapa, Mr Blackwood will sit on the Company's Remuneration Committee and Nominations Committee. 

Mike Buzzacott will retire from his role as Non-Executive Director and Chairman of the Audit and Risk Committee on 30 May 2016. 

James Wallace, Chairman of the Board, commented: "The Board thanks Mike for his contribution to the Board over the last eight years. We are pleased to welcome David to the Board and look forward to leveraging the wealth of experience he brings to the role."

Composition of Board Committees

The following table sets out the composition of the Board Committees effective 1 June 2016:

Committee

Chairman

Members

Audit and Risk

David Blackwood

Martin Sawkins

Richard Perry

James Wallace

 

Nominations

James Wallace

David Blackwood

Martin Sawkins

Richard Perry

 

Remuneration

Martin Sawkins

David Blackwood

Richard Perry

James Wallace

 

The Company makes the following disclosures in relation to Mr Blackwood's appointment in accordance with paragraph (g) of Schedule Two of the AIM Rules for Companies:

1. Director's full name: David Charles Blackwood

Director's age: 57 years

2. Other directorships / partnerships held during the last five years, including appointment and resignation dates:

Name of Company / Partnership

Date appointed

Date resigned

 

 

 

Dignity Plc

01/10/2015

n/a

 

Polymerlatex Limited

31/03/2011

 

01/05/2015

Synthomer plc

01/10/2007

01/05/2015

 

Synthomer Holdings Limited

29/11/2012

01/05/2015

 

Synthomer sprl

 

01/11/2011

01/06/2015

Synthomer (UK) Limited

30/11/2012

30/07/2015

 

 

3. Other information: there is no other information required to be disclosed under paragraph (g) of Schedule Two of the AIM Rules for Companies.

 

 

Enquiries:

Rebecca Smith, Company Secretary Tel: 0161 301 7430

Scapa Group plc

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOASFDFDIFMSEDL
Date   Source Headline
1st Dec 201510:11 amRNSHolding(s) in Company
1st Dec 201510:10 amRNSHolding(s) in Company
30th Nov 201510:34 amRNSTotal Voting Rights
24th Nov 20157:00 amRNSInterim Results
3rd Nov 20154:55 pmRNSHolding(s) in Company
3rd Nov 20154:54 pmRNSShareholder Circular Posted
13th Oct 20157:00 amRNSTrading Statement
10th Sep 20151:03 pmRNSAdditional Listing
9th Sep 20159:48 amRNSHolding(s) in Company
1st Sep 20153:57 pmRNSBlocklisting Interim Review
1st Sep 20153:29 pmRNSAdditional Listing
11th Aug 20151:28 pmRNSAdditional Listing
10th Aug 20159:46 amRNSDirector/PDMR Shareholding
23rd Jul 20159:21 amRNSDirector/PDMR Shareholding
21st Jul 20157:00 amRNSAGM Statement
14th Jul 20153:56 pmRNSAdditional Listing
13th Jul 20151:26 pmRNSHolding(s) in Company
2nd Jul 201511:15 amRNSAdditional Listing
17th Jun 20157:00 amRNSHealthcare Site Visit
16th Jun 20159:15 amRNSAdditional Listing
10th Jun 20152:54 pmRNSHolding(s) in Company
5th Jun 20159:01 amRNSHolding(s) in Company
4th Jun 20159:31 amRNSHolding(s) in Company
3rd Jun 20158:59 amRNSHolding(s) in Company
27th May 20157:00 amRNSFinal Results
28th Apr 20153:27 pmRNSAdditional Listing
9th Apr 20157:00 amRNSTrading Statement
7th Apr 20154:38 pmRNSHolding(s) in Company
7th Apr 20153:43 pmRNSAdditional Listing
31st Mar 20159:12 amRNSTotal Voting Rights
30th Mar 20154:02 pmRNSAdditional Listing
30th Mar 20152:58 pmRNSDirector/PDMR Shareholding
18th Mar 20154:45 pmRNSHolding(s) in Company
16th Mar 20154:20 pmRNSAdditional Listing
10th Mar 20154:10 pmRNSAdditional Listing
9th Mar 20157:00 amRNSHolding(s) in Company
5th Mar 20157:00 amRNSDirector/PDMR Shareholding
5th Mar 20157:00 amRNSDirector/PDMR Shareholding
4th Mar 20157:00 amRNSDirector/PDMR Shareholding
2nd Mar 20153:58 pmRNSAdditional Listing
2nd Mar 20157:00 amRNSAcquisition
23rd Feb 20159:08 amRNSHolding(s) in Company
16th Feb 20159:01 amRNSHolding(s) in Company
13th Feb 20159:09 amRNSHolding(s) in Company
11th Feb 201510:52 amRNSHolding(s) in Company
9th Feb 20151:35 pmRNSHolding(s) in Company
9th Feb 201510:33 amRNSBlocklisting Interim Review
4th Feb 201512:18 pmRNSHolding(s) in Company
23rd Jan 20159:59 amRNSHolding(s) in Company
31st Dec 201412:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.